SCHEMBL20772000

SCHEMBL20772000

CCOC(=O)c1nc(C)cc2sc(Cl)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
CYP1A2 P05177 1/20 0.42
GLP1R P43220 1/20 0.42
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
TRPM8 Q7Z2W7 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 2/20 0.41
GLA P06280 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 3/20 0.40
MAPK1 P28482 2/20 0.40
NPC1 O15118 2/20 0.40
TP53 P04637 2/20 0.40
XBP1 P17861 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20772240 0.81 GABRG2 (0.44) ALDH1A1GLP1RMAPTKDM4EHSD17B10
SCHEMBL20775292 0.73 PTPN1 (0.33) GLP1RHPGDHTT
SCHEMBL20775013 0.72 ALDH1A1 (0.41) ALDH1A1CYP1A2GLP1RMAPTKDM4E
SCHEMBL20771884 0.71 ALDH1A1 (0.36) ALDH1A1MAPTHPGDSMN1; SMN2MAPK1
SCHEMBL20775924 0.70 CNR1 (0.36) ALDH1A1KDM4ENPSR1KMT2A
SCHEMBL20785461 0.70 GLP1R (0.44) ALDH1A1CYP1A2GLP1RMAPTKDM4E
SCHEMBL19740351 0.70 RAB9A (0.51) ALDH1A1CYP1A2MAPTKDM4EHSD17B10
SCHEMBL8143037 0.69 ALDH1A1 (0.47) ALDH1A1CYP1A2GLP1RMAPTKDM4E
SCHEMBL1795334 0.69 TARBP2 (0.44) ALDH1A1CYP1A2GLP1RMAPTKDM4E
SCHEMBL26281309 0.69 ALDH1A1 (0.52) ALDH1A1CYP1A2GLP1RMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675856-A1 COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR Corvus Pharmaceuticals, Inc. (US) 2020-07-08 EP disclosed
WO-2019046784-A1 COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR CORVUS PHARMACEUTICALS, INC. (US) 2019-03-07 WO disclosed